Clinical trial
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis…
NCT00372723 · Loyola University, Other · Withdrawn
Key facts
| NCT number | NCT00372723 |
|---|---|
| Title | Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN) |
| Official title | Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis |
| Lead sponsor | Loyola University, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Toxic Epidermal Necrolysis |
| Intervention type | Drug |
| Interventions | Remicaide (infliximab) |
| Enrollment | 0 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Sep 7, 2006 |
| Last update posted | Apr 26, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: